A phase I study of concurrent radiotherapy and capecitabine as adjuvant treatment for operable rectal cancer

Conclusion: The maximum tolerated dose (MTD) of capecitabine given concurrently with RT was 1,600 mg/m2, daily from the 1st to the 14th day, with a 7-day rest, for two cycles.